SSII SS Innovations International, Inc.
Healthcare$3.77+0.00%OpenMarket Cap: $754.5M
As of 2026-05-26
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
13.98
P/S
16.07
EV/EBITDA
-181.50
DCF Value
$-32.11
FCF Yield
-2.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.4%
Operating Margin
-12.7%
Net Margin
-20.7%
ROE
-23.0%
ROA
-11.1%
ROIC
-9.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $11.1M | $-3.6M | $— |
| Q4 null | $14.5M | $-2.5M | $— |
| FY null | $42.5M | $-12.1M | $— |
| Q3 null | $12.8M | $-3.7M | $— |
Trading Activity
Insider Trades
View AllSudhir Srivastavadirector, 10 percent owner, officer: Chairman and CEO
SellWed May 13
Sudhir Srivastavadirector, 10 percent owner, officer: Chairman and CEO
SellWed Apr 15
Cohen Barry Fdirector, officer: COO - Americas
SellMon Apr 06
Cohen Barry Fdirector, officer: COO - Americas
SellFri Apr 03
Sudhir Srivastavadirector, 10 percent owner, officer: Chairman and CEO
SellWed Apr 01
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.68
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.